Department of Pathology, Cleveland Clinic, Cleveland, Ohio.
Department of Diagnostic Radiology, Cleveland Clinic, Cleveland, Ohio.
Mod Pathol. 2023 Dec;36(12):100347. doi: 10.1016/j.modpat.2023.100347. Epub 2023 Sep 26.
It is not widely recognized that iron (ferrous sulfate) pill aspiration causes airway damage. Clinical diagnosis is challenging because patients are often unaware that they have aspirated a pill. The literature on this entity consists mainly of case reports. The aim of this study is to describe the clinical and pathologic features of iron pill aspiration in a series of 11 patients. A retrospective review of our pathology archives was performed to identify cases of iron pill aspiration (2013-2023). All available histologic and cytologic material was rereviewed. Clinical information was collected from the electronic medical record, and imaging studies were rereviewed. Eighteen endobronchial biopsies were identified from 11 patients (7 women and 4 men; mean age, 70 years; range, 44-82 years). Eight patients had corresponding cytology (20 specimens). Medication history was available in 9 of 11 patients, all of whom were taking iron sulfate pills. Two patients reported possible aspiration episodes; 4 had risk factors for aspiration. The diagnosis of iron pill aspiration was suspected prior to biopsy in only 1 case. Histologically, iron pill particles were yellow, golden brown, or gray, were elongated and crystal or fiber like, and stained strongly with an iron stain. Common histologic findings included mucosal ulceration, acute and/or chronic inflammation, fibrosis, and squamous metaplasia. Iron pill particles were also identified in 11 cytology specimens from 6 patients. On Papanicolaou staining, iron pill particles were yellow to golden, fiber like, refractile, and crystalline. Reactive epithelial cells, squamous metaplasia, and acute inflammation were common. The combination of iron pill intake and discolored mucosa on bronchoscopy is a potential clue to the diagnosis of iron pill aspiration. Pathologists should familiarize themselves with the appearance of iron pill particles in endobronchial biopsies and cytology specimens from the respiratory tract as this diagnosis is seldom suspected on clinical grounds, and most patients lack a history of aspiration.
人们尚未广泛认识到铁(硫酸亚铁)丸剂吸入会导致气道损伤。由于患者通常不知道自己吸入了药丸,因此临床诊断具有挑战性。关于该实体的文献主要由病例报告组成。本研究旨在描述 11 例铁丸剂吸入患者的临床和病理特征。对我们的病理档案进行了回顾性研究,以确定铁丸剂吸入的病例(2013-2023 年)。重新审查了所有可用的组织学和细胞学材料。从电子病历中收集临床信息,并重新审查影像学研究。从 11 例患者中发现了 18 例支气管内活检(7 名女性和 4 名男性;平均年龄 70 岁;范围,44-82 岁)。8 例患者有相应的细胞学(20 个标本)。11 例患者中有 9 例的用药史,均服用硫酸亚铁丸。2 例患者报告可能有吸入事件;4 例有吸入风险因素。仅在 1 例活检前怀疑铁丸剂吸入的诊断。组织学上,铁丸剂颗粒呈黄色、金棕色或灰色,呈长形且呈结晶或纤维状,铁染色强烈染色。常见的组织学发现包括黏膜溃疡、急性和/或慢性炎症、纤维化和鳞状化生。在 6 例患者的 11 例细胞学标本中也发现了铁丸剂颗粒。在巴氏染色上,铁丸剂颗粒呈黄色至金棕色,呈纤维状、有折光性且呈结晶状。反应性上皮细胞、鳞状化生和急性炎症很常见。支气管镜下铁丸剂摄入和黏膜变色的组合是诊断铁丸剂吸入的潜在线索。病理学家应熟悉支气管镜活检和呼吸道细胞学标本中铁丸剂颗粒的外观,因为基于临床原因很少怀疑该诊断,而且大多数患者没有吸入史。